{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:24:36Z","timestamp":1793157876730,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":2446,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.fertnstert.2015.11.043","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T18:06:06Z","timestamp":1449943566000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Prevention of chemotherapy-induced ovarian damage"],"prefix":"10.1016","volume":"105","author":[{"given":"Hadassa","family":"Roness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Kashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Meirow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2015.11.043_bib1","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2013.03.020","article-title":"Current approach to fertility preservation by embryo cryopreservation","volume":"99","author":"Bedoschi","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.fertnstert.2014.06.019","article-title":"Obstetric and perinatal outcome of babies born from vitrified oocytes","volume":"102","author":"Cobo","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.fertnstert.2014.02.052","article-title":"Ovarian tissue cryopreservation: a committee opinion","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib4","first-page":"105","article-title":"Fertility preservation during cancer treatment: clinical guidelines","volume":"6","author":"Rodriguez-Wallberg","year":"2014","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000360199","article-title":"Fertility preservation in young females with hematological malignancies","volume":"132","author":"Shapira","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib6","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.fertnstert.2012.11.057","article-title":"Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients","volume":"99","author":"Chung","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib7","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.fertnstert.2013.03.027","article-title":"Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue","volume":"99","author":"Dolmans","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib10","first-page":"1215","article-title":"Possible mechanisms of paclitaxel-induced apoptosis","volume":"57","author":"Fan","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000077435","article-title":"Paclitaxel treatment of breast cancer cell lines modulates Fas\/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor","volume":"66","author":"Stumm","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/molehr\/gau057","article-title":"Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles","volume":"20","author":"Lopes","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib13","doi-asserted-by":"crossref","first-page":"e42293","DOI":"10.1371\/journal.pone.0042293","article-title":"Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent","volume":"7","author":"Roti Roti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1197-1228","article-title":"Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction","volume":"3","author":"Perez","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/molehr\/5.5.414","article-title":"Fragmentation and death (a.k.a. apoptosis) of ovulated oocytes","volume":"5","author":"Perez","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.reprotox.2010.07.003","article-title":"Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes","volume":"30","author":"Bar-Joseph","year":"2010","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib17","first-page":"185","article-title":"Cyclophosphamide triggers follicle activation causing ovarian reserve \u2018burn out\u2019; AS101 prevents follicle loss and preserves fertility","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/er.2008-0048","article-title":"Molecular mechanisms underlying the activation of mammalian primordial follicles","volume":"30","author":"Adhikari","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib19","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1312830110","article-title":"Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment","volume":"110","author":"Kawamura","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib20","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1073\/pnas.1001198107","article-title":"Activation of dormant ovarian follicles to generate mature eggs","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/molehr\/gau037","article-title":"Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in\u00a0vitro results in increased activation of primordial follicles but compromises development of growing follicles","volume":"20","author":"McLaughlin","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib22","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4161\/cc.26358","article-title":"Ovarian follicle burnout: a universal phenomenon?","volume":"12","author":"Roness","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/toxsci\/kfs137","article-title":"Staying alive: PI3K pathway promotes primordial follicle activation and survival in response to 3-MC induced ovotoxicity","volume":"128","author":"Sobinoff","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1196\/annals.1299.120","article-title":"Tellurium compound AS101 induces PC12 differentiation and rescues the neurons from apoptotic death","volume":"1010","author":"Makarovsky","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib25","first-page":"1499","article-title":"Protective and restorative role of AS101 in combination with chemotherapy","volume":"51","author":"Kalechman","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib26","first-page":"5962","article-title":"The protective role of ammonium trichloro (dioxoethylene-O,O') tellurate in combination with several cytotoxic drugs acting by different mechanisms of action","volume":"53","author":"Kalechman","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib27","first-page":"1838","article-title":"Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in\u00a0vivo and of ASTA-Z 7557 and etoposide in\u00a0vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101)","volume":"53","author":"Kalechman","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0192-0561(92)90122-2","article-title":"The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent","volume":"14","author":"Sredni","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib30","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib31","unstructured":"Roness, H, Derech-Haim, S, Gavish, Z, Meirow, D. Anti-Mullerian c-treatment to prevent chemotherapy-induced activation and loss. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17,\u00a02015."},{"key":"10.1016\/j.fertnstert.2015.11.043_bib32","first-page":"991","article-title":"A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis","volume":"32","author":"Utsunomiya","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib33","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/humrep\/deg507","article-title":"Evidence of apoptosis in human primordial and primary follicles","volume":"18","author":"Depalo","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/80442","article-title":"Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy","volume":"6","author":"Morita","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.mod.2005.04.008","article-title":"Differential expression of p63 isoforms in female reproductive organs","volume":"122","author":"Kurita","year":"2005","journal-title":"Mech Dev"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature05337","article-title":"p63 protects the female germ line during meiotic arrest","volume":"444","author":"Suh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/REP-07-0054","article-title":"p63 null mutation protects mouse oocytes from radio-induced apoptosis","volume":"135","author":"Livera","year":"2008","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA Damage-Induced Primordial Follicle Oocyte Apoptosis and Loss of Fertility Require TAp63-Mediated Induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/em.2850100303","article-title":"Induction and transmission of chemically induced chromosome aberrations in female germ cells","volume":"10","author":"Albanese","year":"1987","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib43","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0030336","article-title":"Birth outcome in women with previously treated breast cancer\u2013a population-based cohort study from Sweden","volume":"9","author":"Dalberg","year":"2006","journal-title":"PLOS Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib44","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"10","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib45","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/mob.2002.126643","article-title":"Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"187","author":"Green","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archpediatrics.2009.112","article-title":"Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis","volume":"163","author":"Mueller","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/cc.4.6.1746","article-title":"Enabling death by the Abl tyrosine kinase: mechanisms for nuclear shuttling of c-Abl in response to DNA damage","volume":"4","author":"Yoshida","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/sj.onc.1201934","article-title":"Functional role for the c-Abl tyrosine kinase in meiosis I","volume":"16","author":"Kharbanda","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib49","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1202571","article-title":"Determination of cell fate by c-Abl activation in the response to DNA damage","volume":"17","author":"Kharbanda","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib50","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib51","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Maiani","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib52","doi-asserted-by":"crossref","first-page":"e70117","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/1568011053765967","article-title":"Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways","volume":"5","author":"Sedletska","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib54","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI30866","article-title":"The p63\/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers","volume":"117","author":"Leong","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib55","doi-asserted-by":"crossref","first-page":"e19475","DOI":"10.1371\/journal.pone.0019475","article-title":"Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants","volume":"6","author":"Soleimani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib56","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.fertnstert.2007.03.065","article-title":"Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?","volume":"89","author":"Kaya","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib57","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.fertnstert.2011.01.012","article-title":"In\u00a0vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates","volume":"95","author":"Zelinski","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.fertnstert.2006.06.020","article-title":"Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in\u00a0vivo","volume":"87","author":"Hancke","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm0902-901","article-title":"Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring","volume":"8","author":"Paris","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib61","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(19901115)66:10<2099::AID-CNCR2820661010>3.0.CO;2-3","article-title":"Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment","volume":"66","author":"Marcello","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib62","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1634\/theoncologist.2012-0172","article-title":"Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity","volume":"17","author":"Ben-Aharon","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib63","doi-asserted-by":"crossref","first-page":"e23492","DOI":"10.1371\/journal.pone.0023492","article-title":"In\u00a0vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels","volume":"6","author":"Bar-Joseph","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib64","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib65","first-page":"832","article-title":"Specific stroma in the cortex and medulla of the ovary. Cell types and vascular supply in relation to follicular apparatus and ovulation","volume":"37","author":"Reeves","year":"1971","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib66","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy","volume":"99","author":"Skaznik-Wikiel","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib67","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.STR.0000208205.26253.96","article-title":"A novel neuroprotectant granulocyte-colony stimulating factor","volume":"37","author":"Solaroglu","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib68","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jtcvs.2012.01.018","article-title":"Effect of granulocyte-colony stimulating factor on expression of selected proteins involved in regulation of apoptosis in the brain of newborn piglets after cardiopulmonary bypass and deep hypothermic circulatory arrest","volume":"143","author":"Pastuszko","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1095\/biolreprod52.2.365","article-title":"Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys","volume":"52","author":"Ataya","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib71","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00404-012-2658-y","article-title":"Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice","volume":"287","author":"Kishk","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7827-11-16","article-title":"Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study","volume":"11","author":"Li","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib73","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/humrep\/deh257","article-title":"The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice","volume":"19","author":"Meirow","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib74","first-page":"269","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial","volume":"20","author":"Del Mastro","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib75","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgindy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib77","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"10","author":"Gerber","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","article-title":"Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer","volume":"10","author":"Munster","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial","volume":"117","author":"Sverrisdottir","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib80","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.2012.42.8185","article-title":"Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial","volume":"31","author":"Demeestere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib81","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12032-013-0667-8","article-title":"Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial","volume":"30","author":"Song","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib82","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib83","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc1504241","article-title":"Ovarian protection during adjuvant chemotherapy","volume":"372","author":"Oktay","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0303-7207(99)00245-2","article-title":"Hormonal regulation of early follicle development in the rat ovary","volume":"163","author":"Hsueh","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib85","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/edrv-11-4-532","article-title":"Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads","volume":"11","author":"Rabinovici","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib86","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib87","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/humrep\/dev037","article-title":"Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?","volume":"30","author":"Hasky","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib88","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.39024","article-title":"Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus","volume":"67","author":"Brunner","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib89","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1200\/JCO.2012.47.8222","article-title":"GnRH agonist for the prevention of chemotherapy-induced ovarian failure in lymphoma","volume":"31","author":"Blumenfeld","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib90","first-page":"2467","article-title":"Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex","volume":"61","author":"Kiyomiya","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib91","doi-asserted-by":"crossref","first-page":"e108174","DOI":"10.1371\/journal.pone.0108174","article-title":"Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice","volume":"9","author":"Roti Roti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14622416.6.2.115","article-title":"Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2","volume":"6","author":"Lepper","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib94","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.fertnstert.2011.01.128","article-title":"Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells","volume":"95","author":"Salih","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib95","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.fertnstert.2013.07.002","article-title":"Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation","volume":"100","author":"Brayboy","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib96","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/CAD.0000000000000182","article-title":"Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes","volume":"26","author":"Tahover","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib97","doi-asserted-by":"crossref","first-page":"e58491","DOI":"10.1371\/journal.pone.0058491","article-title":"Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Ahn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib98","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/sj.cdd.4401819","article-title":"Molecular requirements for doxorubicin-mediated death in murine oocytes","volume":"13","author":"Jurisicova","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib99","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","article-title":"Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model","volume":"25","author":"Akdemir","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2015.11.043_bib100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/humupd\/dmu019","article-title":"Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents","volume":"20","author":"Roness","year":"2014","journal-title":"Hum Reprod Update"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215021275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215021275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:41:47Z","timestamp":1663918907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028215021275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0015028215021275"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.11.043","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of chemotherapy-induced ovarian damage","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}